Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 1026852, 12 pages
http://dx.doi.org/10.1155/2016/1026852
Research Article

A Recipe Composed of Chinese Herbal Active Components Regulates Hepatic Lipid Metabolism of NAFLD In Vivo and In Vitro

1Institute of Liver Diseases, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
2Center for Drug Clinical Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
3Shanghai Key Laboratory of Traditional Chinese Clinical Medicine, Shanghai 201203, China
4E-Institute of Shanghai Municipal Education Committee, Shanghai 201203, China

Received 11 December 2015; Accepted 16 February 2016

Academic Editor: Guoxun Chen

Copyright © 2016 Sheng-xi Meng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. C. Cohen, J. D. Horton, and H. H. Hobbs, “Human fatty liver disease: old questions and new insights,” Science, vol. 332, no. 6037, pp. 1519–1523, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. G. Targher, M. Chonchol, I. Pichiri, and G. Zoppini, “Risk of cardiovascular disease and chronic kidney disease in diabetic patients with non-alcoholic fatty liver disease: just a coincidence?” Journal of Endocrinological Investigation, vol. 34, no. 7, pp. 544–551, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Lazo, R. Hernaez, M. S. Eberhardt et al., “Prevalence of nonalcoholic fatty liver disease in the United States: the third national health and nutrition examination survey, 1988–1994,” American Journal of Epidemiology, vol. 178, no. 1, pp. 38–45, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Ashtari, M. A. Pourhoseingholi, and M. R. Zali, “Non-alcohol fatty liver disease in Asia: prevention and planning,” World Journal of Hepatology, vol. 7, no. 13, pp. 1788–1796, 2015. View at Publisher · View at Google Scholar
  5. L. A. Adams, J. F. Lymp, J. St Sauver et al., “The natural history of nonalcoholic fatty liver disease: a population-based cohort study,” Gastroenterology, vol. 129, no. 1, pp. 113–121, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Milić, I. Mikolasevic, I. Krznaric-Zrnic et al., “Nonalcoholic steatohepatitis: emerging targeted therapies to optimize treatment options,” Drug Design, Development and Therapy, vol. 9, pp. 4835–4845, 2015. View at Publisher · View at Google Scholar
  7. Y. P. Mu, J. Du, and P. Liu, “Herbal prescription experience in the treatment of non-alcoholic steatohepatitis of Professor Liu Ping,” Chinese Journal of Integrated Traditional and Western Medicine on Liver Diseases, vol. 19, no. 3, pp. 170–171, 2009. View at Google Scholar
  8. H. Zhang, Q. Feng, H.-S. Li et al., “Effects of Qushi Huayu Decoction on cathepsin B and tumor necrosis factor-α expression in rats with non-alcoholic steatohepatitis,” Zhong Xi Yi Jie He Xue Bao, vol. 6, no. 9, pp. 928–933, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. Q. Feng, Y. Cheng, Y.-Y. Hu, H. Zhang, J.-H. Peng, and N. Zhang, “Qushi Huayu Decoction (fb) inhibits protein and gene expression of cathepsin B in HepG2 cells induced by free fatty acids,” Chinese Journal of Integrative Medicine, vol. 16, no. 6, pp. 518–524, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. Q. Feng, X.-J. Gou, S.-X. Meng et al., “Qushi huayu decoction inhibits hepatic lipid accumulation by activating AMP-activated protein kinase in vivo and in vitro,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 184358, 14 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. X. Yin, J. Peng, L. Zhao et al., “Structural changes of gut microbiota in a rat non-alcoholic fatty liver disease model treated with a Chinese herbal formula,” Systematic and Applied Microbiology, vol. 36, no. 3, pp. 188–196, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. H.-S. Li, Q. Feng, Y.-Y. Hu et al., “The role of adiponectin and adiponectin receptor 2 in the pathology of fatty liver,” Zhonghua Gan Zang Bing Za Zhi, vol. 17, no. 11, pp. 826–830, 2009. View at Google Scholar · View at Scopus
  13. D. E. Kleiner, E. M. Brunt, M. Van Natta et al., “Design and validation of a histological scoring system for nonalcoholic fatty liver disease,” Hepatology, vol. 41, no. 6, pp. 1313–1321, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. Z.-Z. Meng, J.-H. Hu, J.-X. Chen, and G.-X. Yue, “Xiaoyaosan decoction, a traditional Chinese medicine, inhibits oxidative-stress-induced hippocampus neuron apoptosis in vitro,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 489254, 8 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. M. J. Gómez-Lechón, M. T. Donato, A. Martínez-Romero, N. Jiménez, J. V. Castell, and J.-E. O'Connor, “A human hepatocellular in vitro model to investigate steatosis,” Chemico-Biological Interactions, vol. 165, no. 2, pp. 106–116, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. J. G. Heider and R. L. Boyett, “The picomole determination of free and total cholesterol in cells in culture,” Journal of Lipid Research, vol. 19, no. 4, pp. 514–518, 1978. View at Google Scholar · View at Scopus
  17. H.-S. Li, Q. Feng, and Y.-Y. Hu, “Effect of qushl huayu decoction on high-fat diet induced hepatic lipid deposition in rate,” Zhongguo Zhong Xi Yi Jie He Za Zhi, vol. 29, no. 12, pp. 1092–1095, 2009. View at Google Scholar · View at Scopus
  18. K. T. Fang, “Uniform design: an application of number-theoretic methods to experimental designs,” Acta Mathematicae Applicatae Sinica, vol. 3, no. 4, p. 9, 1980. View at Google Scholar · View at MathSciNet
  19. W. J. Xu, H. H. Zhou, and S. D. Chen, “Uniform design research on complex prescription of Chinese medicine,” Chinese Journal of Experimental Traditional Medical Formulae, vol. 16, no. 13, p. 3, 2010. View at Google Scholar
  20. Q.-L. Fu, Y.-Y. Hu, Q. Feng, X.-N. Wang, J.-H. Peng, and T. Cui, “Analysis of major herbs in Chinese herbal formula Jianpi Huoxue Decoction for improving intestinal permeability based on uniform design,” Zhong Xi Yi Jie He Xue Bao, vol. 9, no. 11, pp. 1234–1241, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. J. D. Browning and J. D. Horton, “Molecular mediators of hepatic steatosis and liver injury,” Journal of Clinical Investigation, vol. 114, no. 2, pp. 147–152, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. R. K. Semple, V. K. K. Chatterjee, and S. O'Rahilly, “PPARγ and human metabolic disease,” Journal of Clinical Investigation, vol. 116, no. 3, pp. 581–589, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. F. A. Monsalve, R. D. Pyarasani, F. Delgado-Lopez, and R. Moore-Carrasco, “Peroxisome proliferator-activated receptor targets for the treatment of metabolic diseases,” Mediators of Inflammation, vol. 2013, Article ID 549627, 18 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Jin, P.-J. Zhang, X.-M. Wu et al., “Impact of hypoxic preconditioning on apoptosis and its possible mechanism in orthotopic liver autotransplantation in rats,” Hepatobiliary and Pancreatic Diseases International, vol. 8, no. 1, pp. 40–45, 2009. View at Google Scholar · View at Scopus
  25. J. Cheng, P.-J. Zhang, C.-Q. Bao et al., “Protective effects of atractylodes macrocephala polysaccharide on liver ischemiareperfusion injury and its possible mechanism in rats,” American Journal of Chinese Medicine, vol. 39, no. 3, pp. 489–502, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. T. Ma, C. Huang, G. Zong et al., “Hepatoprotective effects of geniposide in a rat model of nonalcoholic steatohepatitis,” Journal of Pharmacy and Pharmacology, vol. 63, no. 4, pp. 587–593, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. W.-H. Kuo, C.-J. Wang, S.-C. Young, Y.-C. Sun, Y.-J. Chen, and F.-P. Chou, “Differential induction of the expression of GST subunits by geniposide in rat hepatocytes,” Pharmacology, vol. 70, no. 1, pp. 15–22, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. J. A. Vinson, B. R. Burnham, and M. V. Nagendran, “Randomized, double-blind, placebo-controlled, linear dose, crossover study to evaluate the efficacy and safety of a green coffee bean extract in overweight subjects,” Diabetes, Metabolic Syndrome and Obesity, vol. 5, pp. 21–27, 2012. View at Google Scholar · View at Scopus
  29. K. Kojima, T. Shimada, Y. Nagareda et al., “Preventive effect of geniposide on metabolic disease status in spontaneously obese type 2 diabetic mice and free fatty acid-treated HepG2 cells,” Biological and Pharmaceutical Bulletin, vol. 34, no. 10, pp. 1613–1618, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. C.-W. Wan, C. N.-Y. Wong, W.-K. Pin et al., “Chlorogenic acid exhibits cholesterol lowering and fatty liver attenuating properties by up-regulating the gene expression of PPAR-α in hypercholesterolemic rats induced with a high-cholesterol diet,” Phytotherapy Research, vol. 27, no. 4, pp. 545–551, 2013. View at Publisher · View at Google Scholar · View at Scopus